Related Experiment Videos
4-MTA: a new synthetic drug on the dance scene
Adam R Winstock1, Kim Wolff, John Ramsey
1National Addiction Centre, Institute of Psychiatry, Addiction Sciences Building, 4 Windsor Walk, SE5 8AF, London, UK. kwolff@iop.kcl.ac.uk
Abstract:
4-MTA (p-methylthioamphetamine) is a new synthetic sulphur derivative of amphetamine that has been associated with six deaths since it was first identified in Europe in 1997. Sold as 'ecstasy' or 'Flatliners', the drug like MDMA is a potent serotonin releaser. Using a self-nominated sampling methodology we accessed over 1000 dance drug users through a magazine survey. Ten percent of respondents thought that they had used 4-MTA. Those with experience of 4-MTA tended to come from a sub-population of heavy 'ecstasy'-users. Responses to the effects of the drug were mixed, although about a quarter of those who believed that they had tried 4-MTA thought that they would use it again.
Insights
Four-methylthioamphetamine (4-MTA) is a dangerous amphetamine derivative linked to fatalities. This study surveyed over 1000 ecstasy users, finding 10% believed they had used 4-MTA, often heavy users.
Area of Science:
- Pharmacology
- Toxicology
- Social Sciences
Background:
- 4-methylthioamphetamine (4-MTA) is a novel synthetic amphetamine derivative.
- It has been associated with six fatalities since its 1997 identification in Europe.
- Marketed as 'ecstasy' or 'Flatliners', 4-MTA functions as a potent serotonin releaser, similar to MDMA.
Purpose of the Study:
- To investigate the prevalence of 4-MTA use among dance drug users.
- To understand the user demographics and perceived effects of 4-MTA.
Main Methods:
- A magazine survey utilizing a self-nominated sampling methodology.
- Over 1000 dance drug users were surveyed.
Main Results:
- Ten percent of respondents reported believing they had used 4-MTA.
- Users who had tried 4-MTA were typically heavy 'ecstasy' users.
- Reported effects of 4-MTA were mixed, with approximately 25% indicating willingness to use it again.
Conclusions:
- 4-MTA use appears concentrated within a sub-population of frequent ecstasy users.
- Further research is warranted to fully understand the risks and user perceptions of 4-MTA.